A5112784521- Prenatal Screening and Diagnostics
- Pregnancy and preeclampsia studies
- Parvovirus B19 Infection Studies
- Congenital Anomalies and Fetal Surgery
- Maternal and fetal healthcare
- Assisted Reproductive Technology and Twin Pregnancy
- Fetal and Pediatric Neurological Disorders
- Cardiovascular Issues in Pregnancy
- Maternal and Perinatal Health Interventions
- Birth, Development, and Health
- Blood Coagulation and Thrombosis Mechanisms
- Blood groups and transfusion
- Congenital Diaphragmatic Hernia Studies
- Preterm Birth and Chorioamnionitis
- Folate and B Vitamins Research
- Genomic variations and chromosomal abnormalities
- Gestational Diabetes Research and Management
- Neonatal Respiratory Health Research
- Congenital Heart Disease Studies
- Genetics and Neurodevelopmental Disorders
- Venous Thromboembolism Diagnosis and Management
- Esophageal and GI Pathology
- Tumors and Oncological Cases
- Spinal Dysraphism and Malformations
- Ectopic Pregnancy Diagnosis and Management
Brown University
2009-2019
Women & Infants Hospital of Rhode Island
2009-2019
University at Buffalo, State University of New York
2019
Providence College
2009-2017
Society for Maternal-Fetal Medicine
2013-2015
American Journal Experts (United States)
2008-2013
National Institutes of Health
2005-2013
Yale University
2013
Eunice Kennedy Shriver National Institute of Child Health and Human Development
2006-2013
Thomas Jefferson University
2009-2013
With more than one third of pregnancies in the United States being delivered by cesarean and growing knowledge morbidities associated with repeat deliveries, Eunice Kennedy Shriver National Institute Child Health Human Development, Society for Maternal-Fetal Medicine, American College Obstetricians Gynecologists convened a workshop to address concept preventing first delivery. The available information on maternal fetal factors, labor management induction, nonmedical factors leading delivery...
In Brief Objective: We sought to estimate the frequency of pregnancy-related thromboembolic events among carriers factor V Leiden (FVL) mutation without a personal history thromboembolism, and evaluate impact maternal fetal FVL carriage or other thrombophilias on risk adverse outcomes. Methods: Women with singleton pregnancy no thromboembolism were recruited at 13 clinical centers before 14 weeks gestation from April 2000 August 2001. Each was tested for mutation, as resultant conceptus...
In Brief OBJECTIVE: To estimate whether maternal carriage of the prothrombin gene G20210A mutation is associated with pregnancy loss, preeclampsia, placental abruption, or small for gestational age (SGA) neonates in a low-risk, prospective cohort. METHODS: This was secondary analysis Eunice Kennedy Shriver National Institute Child Health and Human Development factor V Leiden study, multicenter, prospective, observational cohort 5,188 unselected singleton gestations. A total 4,167...
Malignancy complicating pregnancy is fortunately rare, affecting one in 1000 to 1500 pregnancies. Optimal treatment involves balancing the benefit of for mother while minimizing harm fetus. This balance dependent on extent disease, recommended course treatment, and gestational age at which considered. Both surgery chemotherapy are generally safe pregnancy, whereas radiation therapy relatively contraindicated. Iatrogenic prematurity most common complication, as infants often delivered...
There is controversy about whether pathologic abnormalities are associated with pregnancies complicated by factor V Leiden (FVL) mutation. The purpose of this study was to evaluate 105 placentas delivered mothers heterozygous for FVL mutation determine if there changes suggestive hypoxia or thrombosis, which correlate status. We examined obtained as part a prospective 5188 analyzed the presence in either mother infant. One hundred five from were compared 225 controls matched maternal age,...
To determine the efficacy of terbutaline pump for prevention preterm delivery, patients in labor defined by progressive cervical change underwent intravenous magnesium sulfate tocolysis (with or without oral indomethacin, as necessary), and once was arrested, were randomized to one three treatment arms: pump, saline (blinded), terbutaline. If recurrent occurred despite maximization therapy, arm determined therapy changed; switched Patients who continued readmitted aggressive therapy. Women...
In Brief OBJECTIVE: To assess whether functional maternal or fetal genotypes along well-characterized metabolic pathways (ie, CYP1A1, GSTT1, and CYP2A6) may account for varying associations with adverse outcomes among pregnant women who smoke. METHODS: DNA samples from 502 smokers their conceptuses, alongside in a control group, were genotyped known allelic variants of CYP1A1 (Ile462Val AA>AG/GG), GSTT1(del), CYP2A6 (Lys160His T>A). Modification the association between smoking outcome by...